A dual-pronged host-directed therapeutic targeting cyclophilin A and pathogenic interferon response abrogates

Wenzhe Yu1,2, Hongmin Cao2, Zhifang Deng2

  • 1Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Insights

Cyclophilin A (CypA) is essential for Zika virus (ZIKV) replication in the placenta. Inhibiting CypA with ciclosporin A (CsA) blocks ZIKV transmission and reduces fetal harm.

Area of Science:

  • Virology and Immunology
  • Maternal-Fetal Medicine
  • Drug Discovery

Background:

  • Pathogenic viruses can transmit vertically, causing placental immunopathology and threatening fetal development.
  • Mechanisms of viral pathogenesis and effective therapeutics for congenital infections remain significant research gaps.

Purpose of the Study:

  • To identify host factors crucial for Zika virus (ZIKV) replication in human placental cells.
  • To investigate the therapeutic potential of targeting these host factors against ZIKV and related pregnancy complications.

Main Methods:

  • Investigated the role of cyclophilin A (CypA) in ZIKV replication within human placental trophoblasts.
  • Utilized genetic ablation of CypA and pharmacological inhibition with ciclosporin A (CsA).
  • Assessed ZIKV transplacental transmission, placental pathology, and fetal outcomes.
  • Analyzed the impact of CsA on type I interferon signaling pathways (JAK1-STAT1/2).

Main Results:

  • Cyclophilin A (CypA) is essential for ZIKV replication in placental trophoblasts, independent of its known functions.
  • ZIKV infection recruits CypA, disrupting host RNA decay and antiviral surveillance.
  • Genetic deletion or CsA inhibition of CypA significantly restricted ZIKV transplacental transmission and associated pathologies.
  • CsA also ameliorated type I interferonopathies by inhibiting the JAK1-STAT1/2 pathway.

Conclusions:

  • Cyclophilin A (CypA) is a critical host factor in ZIKV pathogenesis and placental infection.
  • Ciclosporin A (CsA) demonstrates dual efficacy by inhibiting ZIKV replication and counteracting pathological interferon responses.
  • CsA represents a promising therapeutic candidate for managing congenital viral infections and pregnancy-specific interferonopathies.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...